more to come
more to come
Most Popular
Sponsored
TGT's 8% April surge outpaces WMT despite prior woes. Analysts raise EPS estimates, but can TGT meet lofty turnaround expectations?
VIPS exits $38.5M stake after 28% return; market cap $7.5B, yield 3.98%. Faces headwinds.
Pediatrix Medical Group's 36% gain is tempting, but tepid sales growth & falling ROIC signal risk despite a 9.9x P/E.
Trump invoked the Defense Production Act to boost US oil production, refining and logistics, enabling federal funding and faster project approvals to strengthen energy security amid rising geopolitical risks.
Meta's 2% YTD return lags S&P 500. P/E of 29 signals potential risk despite AI bets.
ZION's revenue missed estimates, but EPS beat. TBVPS growth is accelerating, yet stock dipped 1.6%.
ASML faces new China export bans, risking revenue from DUV machines & service. Valuation may dip.
Sponsored
Must Read